Characterizing interspecies uncertainty using data from studies of anti-neoplastic agents in animals and humans.

For most chemicals, the Reference Dose (RfD) is based on data from animal testing. The uncertainty introduced by the use of animal models has been termed interspecies uncertainty. The magnitude of the differences between the toxicity of a chemical in humans and test animals and its uncertainty can be investigated by evaluating the inter-chemical variation in the ratios of the doses associated with similar toxicological endpoints in test animals and humans. This study performs such an evaluation on a data set of 64 anti-neoplastic drugs. The data set provides matched responses in humans and four species of test animals: mice, rats, monkeys, and dogs. While the data have a number of limitations, the data show that when the drugs are evaluated on a body weight basis: 1) toxicity generally increases with a species' body weight; however, humans are not always more sensitive than test animals; 2) the animal to human dose ratios were less than 10 for most, but not all, drugs; 3) the current practice of using data from multiple species when setting RfDs lowers the probability of having a large value for the ratio. These findings provide insight into inter-chemical variation in animal to human extrapolations and suggest the need for additional collection and analysis of matched toxicity data in humans and test animals.

[1]  Robert Tibshirani,et al.  An Introduction to the Bootstrap , 1994 .

[2]  L. Whitfield,et al.  Pharmacokinetic and toxicity scaling of the antitumor agents amsacrine and CI-921, a new analogue, in mice, rats, rabbits, dogs, and humans. , 1990, Cancer research.

[3]  Rashmi S. Nair,et al.  Selecting a more realistic uncertainty factor: Reducing compounding effects of multiple uncertainties , 1995 .

[4]  K. Schneider,et al.  Allometric principles for interspecies extrapolation in toxicological risk assessment--empirical investigations. , 2004, Regulatory toxicology and pharmacology : RTP.

[5]  J. Evans,et al.  Estimating Noncancer Uncertainty Factors: Are Ratios NOAELs Informative? , 1999, Risk analysis : an official publication of the Society for Risk Analysis.

[6]  Ralph L Kodell,et al.  On the use of hierarchical probabilistic models for characterizing and managing uncertainty in risk/safety assessment. , 2007, Risk analysis : an official publication of the Society for Risk Analysis.

[7]  E J Freireich,et al.  Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey, and man. , 1966, Cancer chemotherapy reports.

[8]  J S Evans,et al.  Limitations to Empirical Extrapolation Studies: the Case of Bmd Ratios Limitations to Empirical Extrapolation Studies: the Case of Bmd Ratios By , 2000 .

[9]  D. Barnes,et al.  Reference dose (RfD): description and use in health risk assessments. , 1988, Regulatory toxicology and pharmacology : RTP.

[10]  V. Devita,et al.  Animal toxicology for early clinical trials with anticancer agents. , 1981, Cancer clinical trials.

[11]  F Y Bois,et al.  Interspecies extrapolation: a reexamination of acute toxicity data. , 1992, Risk analysis : an official publication of the Society for Risk Analysis.

[12]  S. Marsoni,et al.  Relation of preclinical toxicology to findings in early clinical trials. , 1986, Cancer treatment reports.

[13]  D. Rall,et al.  The evaluation of anticancer drugs in dogs and monkeys for the prediction of qualitative toxicities in man , 1970, Clinical pharmacology and therapeutics.

[14]  C. S. Weil,et al.  Safety Evaluation of Chemicals, Relationship between Short-and Long-Term Feeding Studies in Designing an Effective Toxicity Test , 1963 .

[15]  M E Andersen,et al.  Tissue dosimetry, pharmacokinetic modeling, and interspecies scaling factors. , 1995, Risk analysis : an official publication of the Society for Risk Analysis.

[16]  M Slavik,et al.  Quantitative prediction of drug toxicity in humans from toxicology in small and large animals. , 1975, Cancer research.

[17]  M L Dourson,et al.  An Approach for Modeling Noncancer Dose Responses with an Emphasis on Uncertainty , 1997, Risk analysis : an official publication of the Society for Risk Analysis.

[18]  Paul S. Price,et al.  Defining the Interindividual (Intraspecies) Uncertainty Factor , 1999 .

[19]  M L Dourson,et al.  Regulatory history and experimental support of uncertainty (safety) factors. , 1983, Regulatory toxicology and pharmacology : RTP.

[20]  L. Tuxen,et al.  Integrated risk information system (IRIS) , 1990 .

[21]  Efsa Scientific Colloquium.  Development of food-based dietary guidelines : 21-22 March 2006 - Parma, Italy , 2007 .

[22]  Ulrike Schuhmacher-Wolz,et al.  Uncertainty in toxicological risk assessment for non-carcinogenic health effects. , 2003, Regulatory toxicology and pharmacology : RTP.

[23]  F Kalberlah,et al.  Time extrapolation and interspecies extrapolation for locally acting substances in case of limited toxicological data. , 2002, The Annals of occupational hygiene.

[24]  L R Rhomberg,et al.  Empirical Scaling of Single Oral Lethal Doses Across Mammalian Species Based on a Large Database , 1998, Risk analysis : an official publication of the Society for Risk Analysis.

[25]  John L. Adgate,et al.  Subchronic to chronic exposure extrapolation: Toxicologic evidence for a reduced uncertainty factor , 1995 .

[26]  W. Slob,et al.  Integration of Probabilistic Exposure Assessment and Probabilistic Hazard Characterization , 2007 .

[27]  J. Evans,et al.  Reproductive and Developmental Risks from Ethylene Oxide: A Probabilistic Characterization of Possible Regulatory Thresholds , 2001, Risk analysis : an official publication of the Society for Risk Analysis.

[28]  Wout Slob,et al.  Deriving a Data-Based Interspecies Assessment Factor Using the NOAEL and the Benchmark Dose Approach , 2007, Critical reviews in toxicology.

[29]  Paul S. Price,et al.  Application of Quantitative Information on the Uncertainty in the RfD to Noncarcinogenic Risk Assessments , 1999 .

[30]  W Slob,et al.  Assessment factors for human health risk assessment: a discussion paper. , 1999, Critical reviews in toxicology.

[31]  Michael Dourson,et al.  A Probabilistic Framework for the Reference Dose (Probabilistic RfD) , 1998 .

[32]  Susan A. Murphy,et al.  Monographs on statistics and applied probability , 1990 .

[33]  Peter M. J. Bos,et al.  Probabilistic assessment factors for human health risk assessment. A practical guide , 2001 .

[34]  W Mertz,et al.  Risk assessment of essential elements. , 1993, Scandinavian journal of work, environment & health.

[35]  C C Travis,et al.  Interspecific scaling of toxicity data. , 1988, Risk analysis : an official publication of the Society for Risk Analysis.

[36]  M. Pieters,et al.  A Probabilistic Approach for Deriving Acceptable Human Intake Limits and Human Health Risks from Toxicological Studies: General Framework , 1998, Risk analysis : an official publication of the Society for Risk Analysis.

[37]  B E Storer,et al.  Design and analysis of phase I clinical trials. , 1989, Biometrics.

[38]  Bruce D. Naumann,et al.  Scientific basis for uncertainty factors used to establish occupational exposure limits for pharmaceutical active ingredients , 1995 .

[39]  Sandra J. S. Baird,et al.  Noncancer Risk Assessment: A Probabilistic Alternative to Current Practice , 1996 .

[40]  Wout Slob,et al.  Probabilistic risk characterization: an example with di(2-ethylhexyl) phthalate. , 2005, Regulatory toxicology and pharmacology : RTP.

[41]  Thomas A. Lewandowski,et al.  Methods for Identifying a Default Cross-Species Scaling Factor , 2006 .

[42]  C. S. Weil.  Guidelines for experiments to predict the degree of safety of a material for man. , 1972, Toxicology and applied pharmacology.